Skip to main content
. 2019 May 15;18(1):802–816. doi: 10.3892/etm.2019.7579

Figure 7.

Figure 7.

Summary of the subgroup analysis of adverse effects after N-acetylcysteine therapy for idiopathic pulmonary fibrosis.